Skip to content

FOREward Together: Training Peer Recovery Coaches to Promote Retention and Adherence to MOUD

Training Peer Recovery Coaches to Promote Retention and Adherence to Medications for Opioid Use Disorder Among Low-Income Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05098795
Enrollment
29
Registered
2021-10-28
Start date
2021-12-01
Completion date
2023-08-14
Last updated
2025-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Use

Keywords

Medications for opioid use disorder, Peer recovery coach, Substance use, Behavioral activation, Task sharing, Treatment retention

Brief summary

This project aims to implement a peer-led intervention to support retention and adherence to medications for opioid use disorder among low-income adults in Detroit, as well as a training manual for peer recovery coaches serving similar populations. The approach will serve as a guide to coaches in providing positive reinforcement and helping those in treatment to schedule and engage in valued activities. Researchers will examine the effectiveness of the intervention, supervision and training models, and share results with policymakers and treatment programs.

Detailed description

Low-income and racial/ethnic minorities suffer disproportionately from the opioid use disorder (OUD) crisis, evidencing consistently lower rates of critical treatment outcomes, including medication for OUD (MOUD) engagement and retention. While these individuals exhibited a need for evidence-based care prior to the pandemic, low-income, racial/ethnic minority populations have been disproportionately affected by COVID-19, as have persons with SUDs. Peer Recovery Coaches (PRC) are individuals with lived-experiences with substance use who have been certified by the state to assist in treatment recovery. Because of similarities between PRCs and substance use clients, PRCs can overcome many of the barriers that clients face to engaging and staying in MOUD treatment, such as stigma. goal of the current project is to conduct an open-label pilot trial to examine the feasibility, acceptability and accessibility of a PRC-led intervention to support retention in MOUD care. This project proposes to develop a novel and sustainable model for improving retention in MOUD treatment by training PRCs to deliver an evidence-based intervention (EBI), Behavioral Activation (BA). BA seeks to increase the positive reinforcement patients experience from their natural environment by promoting prosocial and valued experiences. BA has been found to improve substance use treatment retention and adherence, as well as medication adherence in low-income individuals with HIV/AIDS. To that end, the following goal is proposed: to evaluate the preliminary feasibility, acceptability, and effectiveness of the PRC- delivered BA approach. An open-label pilot trial (n=40) of the adapted PRC-delivered BA intervention and training protocol in a representative agency in Detroit, MI serving a low-income, predominantly African-American population will be conducted. Findings from this phase of the project will be used to re-adapt the manual and training procedures.

Interventions

BA seeks to increase the positive reinforcement patients experience from their natural environment by promoting prosocial and valued experiences. BA has been found to improve substance use treatment retention and adherence, as well as medication adherence in low-income individuals with HIV/AIDS.

Sponsors

University of Maryland, College Park
CollaboratorOTHER
Henry Ford Health System
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants must (1) be receiving or referred to MOUD; and (2) be over the age of 18.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
MOUD Retention RateMeasured between participants' completion of baseline assessment and completion of the follow-up assessment (approximately 8-12 weeks following the intervention date).Average number of days a participant missed an MOUD appointment between receiving the intervention and completing the follow-up assessment (approximately 8-12 weeks following the intervention date), averaged across all participants with available data.
Intervention Fidelity: Proportion of Intervention Components Delivered as IntendedThe number of days between starting the intervention and completing the intervention (approximately 8-10 weeks).Defined as the proportion of all 24 intervention components in the total intervention that were delivered with fidelity by the interventionist (ranging from 0 to 1.0 with higher proportion reflecting more fidelity).

Secondary

MeasureTime frameDescription
Intervention Acceptability: Percentage of Patients Enrolled Who Attend ≥75% SessionsThe number of days between starting the intervention and completing the intervention (approximately 8-10 weeks).Defined as the percentage of participants who started the intervention who then finish the intervention (defined as completing 8 total sessions)
Intervention Feasibility: Percentage of Patients Who Consents Who Started BAThe number of days between starting providing consent and starting BA (approximately 1-5 weeks).Defined as the percentage of participants who started BA sessions relative to those who enrolled in the program

Countries

United States

Participant flow

Recruitment details

Participants were enrolled via flyers and word-of-mouth at a community-based substance use treatment setting from December 2021 through April 2023.

Participants by arm

ArmCount
Peer-delivered Behavioral Activation
Adults 18 years or older on MOUD or referred to MOUD will receive Behavioral Activation (BA) an evidence-based intervention (EBI) by trained Peer Recovery Coaches (PRC) Behavioral Activation (BA): BA seeks to increase the positive reinforcement patients experience from their natural environment by promoting prosocial and valued experiences. BA has been found to improve substance use treatment retention and adherence, as well as medication adherence in low-income individuals with HIV/AIDS.
29
Total29

Baseline characteristics

CharacteristicPeer-delivered Behavioral Activation
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
28 Participants
Age, Continuous46.6 Years
STANDARD_DEVIATION 13.6
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
26 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
25 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
White
2 Participants
Region of Enrollment
United States
29 participants
Sex: Female, Male
Female
10 Participants
Sex: Female, Male
Male
19 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
1 / 29
other
Total, other adverse events
0 / 29
serious
Total, serious adverse events
0 / 29

Outcome results

Primary

Intervention Fidelity: Proportion of Intervention Components Delivered as Intended

Defined as the proportion of all 24 intervention components in the total intervention that were delivered with fidelity by the interventionist (ranging from 0 to 1.0 with higher proportion reflecting more fidelity).

Time frame: The number of days between starting the intervention and completing the intervention (approximately 8-10 weeks).

Population: Fidelity was examined among participants who took part in at least one BA session.

ArmMeasureValue (MEAN)Dispersion
Peer-delivered Behavioral ActivationIntervention Fidelity: Proportion of Intervention Components Delivered as Intended.83 proportion of elements deliveredStandard Deviation 0.09
Primary

MOUD Retention Rate

Average number of days a participant missed an MOUD appointment between receiving the intervention and completing the follow-up assessment (approximately 8-12 weeks following the intervention date), averaged across all participants with available data.

Time frame: Measured between participants' completion of baseline assessment and completion of the follow-up assessment (approximately 8-12 weeks following the intervention date).

Population: We were able to get data on MOUD visits from 18 participants from the total sample.

ArmMeasureValue (MEAN)Dispersion
Peer-delivered Behavioral ActivationMOUD Retention Rate.42 number of days missed MOUD appointmentStandard Deviation 2.86
Secondary

Intervention Acceptability: Percentage of Patients Enrolled Who Attend ≥75% Sessions

Defined as the percentage of participants who started the intervention who then finish the intervention (defined as completing 8 total sessions)

Time frame: The number of days between starting the intervention and completing the intervention (approximately 8-10 weeks).

Population: We examined the percentage of all participants who started the intervention who then completed the intervention (defined as taking part in 8 sessions)

ArmMeasureValue (NUMBER)
Peer-delivered Behavioral ActivationIntervention Acceptability: Percentage of Patients Enrolled Who Attend ≥75% Sessions62 percentage of participants
Secondary

Intervention Feasibility: Percentage of Patients Who Consents Who Started BA

Defined as the percentage of participants who started BA sessions relative to those who enrolled in the program

Time frame: The number of days between starting providing consent and starting BA (approximately 1-5 weeks).

Population: We examined the percentage of participants who took part in at least one BA session relative to those who enrolled.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Peer-delivered Behavioral ActivationIntervention Feasibility: Percentage of Patients Who Consents Who Started BA21 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026